<html>
<head>PUBMED IDs for CACNL1A3</head>
<body bgcolor='#C5F0F2'><h1>CACNL1A3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8395939/'>Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect.</a> July 1  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/8395937/'>Mutation analysis in patients with the typical form of Anderson-Fabry disease.</a> July 1  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/8188298/'>Refined localization of the alpha 1-subunit of the skeletal muscle L-type voltage-dependent calcium channel (CACNL1A3) to human chromosome 1q32 by in situ hybridization.</a> February 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7847370/'>Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families.</a> February 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8838325/'>The structure of the gene encoding the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3).</a> February 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9066893/'>Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families.</a> March 3  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9331079/'>A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spot.</a> October 23  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9436445/'>[Mutation analysis of the CACNL1A3 gene in Japanese hypokalemic periodic paralysis families].</a> January 22  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10881598/'>Hypokalemic periodic paralysis and mutations in the CACNL1A3 gene: case study in a Japanese family.</a> July 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11034874/'>Clinical-molecular study of a family with essential tremor, late onset seizures and periodic paralysis.</a> October 18  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11034811/'>Progressive loss of perivascular nerves adjacent to colorectal cancer.</a> October 18  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11034640/'>Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders.</a> October 18  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11216663/'>Does the A3333G mutation in the CACNL1A3 gene, detected in malignant hyperthermia, also occur in central core disease?</a> February 24  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11353725/'>Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.</a> May 17  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11808349/'>[A case of familial hypokalemic periodic paralysis with hyperuricemia during paralytic attack and genetic analysis of the pedigree].</a> January 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14500992/'>Screening for mutations in the RYR1 gene in families with malignant hyperthermia.</a> September 23  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15482957/'>Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation.</a> October 16  2004<br></body></html>
